Learn who is responsible under EU GPSR. Understand the Responsible Person framework, economic operator roles, and compliance obligations for EU market access.

Andulka
taylor price
untitled
todays bird
Today's Document
official daine visual archive
"I'm Dorothy Gale from Kansas"

Kiana Khansmith
2025 on Tumblr: Trends That Defined the Year
d e v o n

ellievsbear
The Stonewall Inn
Sade Olutola
🪼
YOU ARE THE REASON
icyghini twinkie
Show & Tell

blake kathryn
almost home
No title available

seen from Argentina

seen from Uzbekistan

seen from Malaysia
seen from United States

seen from Italy
seen from Netherlands

seen from Mexico

seen from United States
seen from United States

seen from Germany

seen from Venezuela
seen from United States
seen from United States
seen from Philippines
seen from United States

seen from United States
seen from Luxembourg

seen from Germany
seen from Uruguay

seen from Argentina
@freyrgri
Learn who is responsible under EU GPSR. Understand the Responsible Person framework, economic operator roles, and compliance obligations for EU market access.
Stay compliant with New Zealand’s HSRN portal. Understand HSNO regulations, deadlines, and reporting requirements to avoid operational risks.
New Zealand HSRN Portal Guide: HSNO Chemical Compliance
The HSRN Portal Has Changed the Rules for Hazardous Substance Compliance in New Zealand
New Zealand's Environmental Protection Authority (EPA) has moved hazardous substances reporting onto a single digital system: the Hazardous Substances Reporting and Notifications (HSRN) portal. For compliance managers, health and safety officers, and supply chain executives, this is more than a system upgrade — it changes how businesses register chemicals, report activity, and interact with the regulator under the Hazardous Substances and New Organisms Act (HSNO Act).
Compliance is no longer a once-a-year filing exercise. Under the framework, importers and manufacturers now need an ongoing process for keeping business and product information current, submitting timely notifications, and filing annual reports — all through the HSRN portal. Businesses that don't adapt risk falling out of step with a regulator that now has real-time visibility into who is importing and manufacturing what.
The 30-Day Window for New Substances
The most important operational detail in the new framework is the reporting deadline for new hazardous substance activity.
The requirement: Importers and manufacturers must submit business information to the EPA within 30 days of first importing or manufacturing a given hazardous substance.
Ongoing obligation: This isn't a one-off. Any changes to your business information — including new substances brought into your import or manufacturing activity — must also be updated in the portal within 30 days of the change.
Who it applies to: The obligation covers importers and manufacturers supplying hazardous substances to others or for workplace use, including certain explosives and agrichemicals. Re-packagers and re-labellers are excluded, and bulk active ingredients only need reporting once they're incorporated into a finished product.
Annual reporting is separate: If your substances or activities require it, you'll also need to file an annual report. Reports for the 2025 calendar year are due by 31 May 2026, and annual reports for each calendar year afterward will follow the same 31 May deadline.
Information to Have Ready Before You Log In
Gathering the right data before you start a submission will save time and reduce the risk of an incomplete filing:
Substance identifiers: Product name, and either the HSNO approval number, the individual approval name, or the relevant group standard name.
Approval details: You can find your substance's HSNO approval information in Section 15 of its Safety Data Sheet (SDS).
GHS 7 classification: Hazard classifications should be current and consistent with what's on file with the EPA.
Business information: Your business profile details need to be accurate and up to date — this applies even if you've provided this information to the EPA before.
Quantity data: For annual reporting, you may need to calculate active ingredient amounts, including converting salt or ester forms to their acid-equivalent value where relevant.
A Practical Action Plan for Compliance Teams
Audit your product inventory. Review every hazardous substance you currently import, manufacture, or hold, and confirm its HSNO approval status.
Set up your HSRN portal profile. Make sure the right people in your organisation have access, and confirm you're working in the correct business profile if your organisation has more than one.
Cross-check your SDSs. Confirm hazard classifications in your Safety Data Sheets match GHS 7 requirements and align with your HSNO approvals.
Build in a 30-day trigger. Link customs clearance or production completion dates to an internal alert so your regulatory team never misses the reporting window.
Track the annual reporting deadline separately. Note the 31 May cutoff each year for substances that require an annual report.
Getting Support
Keeping pace with an active reporting regime — rather than periodic paperwork — takes coordination between technical, regulatory, and supply chain teams. If you'd like help auditing your portfolio or setting up a reporting process, Freyr's regulatory compliance team can support a full portfolio review against current EPA requirements.
This article reflects EPA guidance as published on epa.govt.nz. Requirements can change, so confirm current obligations directly with the EPA before making compliance decisions.
Explore our PPWR infographic to learn how the EU Packaging and Packaging Waste Regulation is transforming packaging design, recyclability, and compliance.
Explore the EU PPWR roadmap with key packaging compliance milestones, timelines, and documentation requirements for successful EU market access.
Learn Indonesia halal certification requirements for cosmetics, BPJPH registration, SIHALAL process, compliance deadlines, and market entry guidance.
Indonesia Halal Certification for Cosmetics | Complete Guide
Halal Certification for Cosmetics in Indonesia: What Brands Need to Know
Indonesia's cosmetics industry is changing fast, and halal compliance is now central to that shift. What was once a voluntary marketing claim is quickly becoming a baseline requirement for accessing the market and earning consumer trust. Any brand entering or growing in Indonesia needs a solid grasp of halal certification and registration rules — both to stay compliant and to build credibility with local consumers.
The Regulatory Framework
Halal certification in Indonesia sits under Law No. 33 of 2014 on Halal Product Assurance, further detailed by Government Regulation No. 42 of 2024. Under this framework, any cosmetic product marketed with a halal claim must carry official halal certification. Products formulated with non-halal ingredients aren't required to certify, but they do need clear, accurate labeling that identifies them as non-halal, in line with regulatory standards.
Three bodies share responsibility for running the system:
BPJPH (the Halal Product Assurance Organizing Agency) — oversees the overall process
LPH (Halal Inspection Agencies) — carry out audits
MUI (Indonesian Ulema Council) — issues the halal ruling, or fatwa
The Certification Deadline: October 17, 2026
This date matters. As things currently stand, it's the deadline for cosmetics and personal care products to secure halal certification. Miss it, and companies risk administrative penalties, restricted market access, or other enforcement action if their products aren't properly certified or labeled.
How the Certification Process Works
Getting certified follows five main stages:
Documentation — Companies compile product formulations, ingredient lists, supplier certifications, manufacturing flowcharts, and relevant business licenses.
Filing through SIHALAL — Applications go through BPJPH's online platform, which standardizes registration and lets companies track progress.
Audit and verification — LPH inspects raw materials, production methods, and facilities to confirm halal integrity throughout.
Fatwa decision — MUI reviews the audit findings and rules on whether the product satisfies Islamic requirements.
Certificate issuance — BPJPH grants the halal certificate, clearing the product for the Indonesian market.
What Cosmetic Brands Need to Have in Place
To move through certification successfully, companies should be able to demonstrate:
Traceable, halal-compliant ingredients throughout the supply chain
Compliant labeling — legible, with halal or non-halal status clearly stated alongside ingredients, net weight, manufacturing and expiry dates, usage instructions, and any warnings. Imagery involving pigs, pork, or alcoholic beverages should be avoided, since it conflicts with a halal claim.
Controlled production, with proper segregation from non-halal materials
A functioning Halal Assurance System (SJPH)
A designated Halal Supervisor (Penyelia Halal) responsible for ongoing compliance
Foreign cosmetics companies also need a local representative or importer to manage submissions and approvals on their behalf, since direct filing isn't an option for overseas entities.
The Bigger Picture
Indonesia's halal framework doesn't stop at the ingredient list — it runs across the entire supply chain, from sourcing through to distribution. For cosmetic brands, treating halal certification purely as a compliance exercise misses the point. Done well, it's a chance to build supply chain transparency, strengthen brand trust, and gain a foothold in one of the largest halal beauty markets in the world.
With the October 2026 deadline approaching, brands that start planning now — and build the internal systems to support it — will be far better positioned than those scrambling at the last minute.
For guidance navigating Indonesia's halal certification requirements, consult Freyr's regulatory experts.
FSSAI ePAAS is now mandatory. Discover 6 essential checks for product approvals, claims, notifications, and regulatory submissions to help avoid delays.
🚨Your regulatory updates have arrived at border control.
Every regulatory update deserves the right level of attention—but finding the important ones among countless alerts, guidance documents, and market changes isn't easy.
freya.intelligence helps regulatory teams cut through the noise by filtering relevant updates, validating trusted sources, and providing the context needed to make faster, more informed decisions.
Spend less time searching and more time acting on what matters.
Start your 14-day free trial today: https://www.freyrregintel.com/freya-intelligence/
When your regulatory workflow feels like a never-ending inbox… 📩
Missed updates, manual tracking, disconnected tools, and unclear impact make regulatory work harder than it needs to be.
freya.intelligence brings everything together in one AI-powered platform, helping teams monitor global regulations, understand changes, and make faster, informed decisions.
See the difference yourself. Start your free trial today: https://www.freyrregintel.com/freya-intelligence/
Is your regulatory intelligence tool only helping you find updates or helping your team decide what to do next?
For life sciences companies, regulatory intelligence can no longer stop at alerts, databases, or keyword search. Teams need context, relevance, traceability, and AI-powered support that helps turn regulatory change into informed action.
Read the full blog to explore what a modern RI tool should really do for regulatory teams today:
This blog talks about how a regulatory intelligence tool helps life sciences companies for global monitoring, regulatory impact assessment a
Manual Regulatory Monitoring Is Quietly Costing Life Sciences Teams More Than They Realize
If you've ever spent an afternoon jumping between regulatory authority websites, downloading guidance documents, updating spreadsheets, and forwarding emails to colleagues, you're not alone.
For many regulatory affairs professionals, this has been the standard way of working for years.
But here's the question worth asking:
Is manual regulatory monitoring still sustainable?
The volume of regulatory information published by health authorities continues to grow. Pharmaceutical companies, biotechnology firms, medical device manufacturers, and cosmetics organizations are expected to monitor hundreds of updates across multiple countries—all while supporting product development, submissions, and ongoing compliance.
At some point, the challenge stops being about finding information.
It becomes about managing it effectively.
The Regulatory Landscape Never Stands Still
Healthcare regulations evolve constantly.
Authorities publish new guidance, amend existing regulations, release safety alerts, update submission procedures, and introduce new compliance expectations throughout the year.
Each announcement might appear minor on its own.
Collectively, however, they shape how organizations develop products, prepare regulatory submissions, manage product lifecycles, and expand into global markets.
Missing even one important update can create unnecessary delays, additional work, or increased compliance risk.
That's why regulatory awareness has become a continuous responsibility rather than an occasional task.
The Hidden Cost of Manual Processes
Many organizations still rely on traditional monitoring methods.
These often include:
Visiting multiple regulatory authority websites every day
Maintaining spreadsheets of regulatory updates
Searching through lengthy PDF documents
Sharing information through email chains
Manually assessing business impact
While these activities seem manageable individually, they consume significant time over weeks and months.
More importantly, they leave highly skilled regulatory professionals spending valuable hours collecting information instead of analyzing it.
Information Is Everywhere—Insights Are Not
Access to regulatory information has improved dramatically.
The problem today isn't availability.
It's volume.
Thousands of documents, notifications, consultation papers, technical standards, and regulatory announcements are published every year.
Finding the right information quickly—and understanding whether it actually affects your products—is becoming increasingly difficult.
Organizations need more than notifications.
They need context.
How Regulatory Intelligence Changes the Process
A modern regulatory intelligence platform transforms scattered information into organized knowledge.
Instead of checking dozens of websites individually, regulatory teams can monitor updates from multiple authorities through a centralized system.
More importantly, they can focus on interpreting changes rather than searching for them.
Effective regulatory intelligence supports activities such as:
Monitoring global regulatory developments
Searching regulations and guidance documents efficiently
Understanding potential business impact
Supporting regulatory change management
Improving collaboration across departments
Building a centralized regulatory knowledge base
The result isn't simply faster research.
It's better decision-making.
Artificial Intelligence Is Becoming Part of Regulatory Affairs
AI has become one of the most discussed technologies across life sciences.
In regulatory affairs, its value isn't about replacing human expertise.
It's about helping professionals work more efficiently.
AI-assisted capabilities can help summarize lengthy guidance documents, locate relevant information, compare regulatory requirements, and accelerate research activities.
Regulatory professionals still make the final decisions.
AI simply reduces the time spent processing information manually.
That combination of technology and human expertise is likely to define the future of regulatory operations.
Regulatory Intelligence Benefits the Entire Organization
Although regulatory affairs teams are often the primary users, regulatory intelligence supports many business functions.
Quality teams gain better visibility into changing requirements.
Product development teams can incorporate regulatory expectations earlier.
Leadership gains insights that support strategic planning and market expansion.
Commercial teams better understand evolving market requirements.
When regulatory knowledge is shared across the organization, decision-making becomes faster and more consistent.
Looking Forward
Healthcare innovation will continue accelerating.
As therapies become more advanced and global regulations become increasingly interconnected, organizations will need smarter ways to manage regulatory complexity.
Companies that continue relying exclusively on manual monitoring may struggle to keep pace with the growing volume of regulatory information.
Those investing in regulatory intelligence platforms and AI-assisted research will be better prepared to adapt, innovate, and remain compliant in a rapidly changing global environment.
Want to explore this topic further?
This article provides a broad perspective on why regulatory intelligence is becoming increasingly important across the life sciences industry.
For a detailed look at how a modern Regulatory Intelligence Tool supports global regulatory monitoring, AI-powered research, regulatory impact assessment, change management, and smarter compliance decisions, read the complete guide from Freyr RegIntel:
👉 https://www.freyrregintel.com/everything-a-regulatory-intelligence-tool-can-do-for-life-sciences-companies/
Because in today's regulatory environment, success isn't determined by who gathers the most information—it's determined by who can turn that information into meaningful action the fastest.
Learn MoCRA facility registration requirements, FDA compliance, renewal timelines, and US Agent obligations. Explore the quick guide from Freyr Solutions.
Learn what MoCRA is, why it matters, key FDA cosmetic requirements, and how it impacts manufacturers. Explore Freyr's guide to stay compliant.
What Is MoCRA? A Guide to US FDA Cosmetics Compliance
MoCRA: The Modernization of Cosmetics Regulation Act of 2022
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) is a major overhaul of how cosmetic products are regulated in the United States. Signed into law on December 29, 2022, as part of the Consolidated Appropriations Act of 2023, MoCRA represents the biggest expansion of the FDA's authority over cosmetics since the Federal Food, Drug, and Cosmetic Act was first passed in 1938. With this law now in place, the FDA has a much stronger set of tools to help keep everyday cosmetic products safe for consumers.
Why MoCRA Matters
Prior to MoCRA, FDA oversight of the cosmetics industry was fairly minimal. Companies weren't obligated to register their manufacturing facilities, disclose adverse events, or provide evidence that their products were safe, and recalling unsafe products was purely voluntary.
MoCRA closes these gaps by putting a modern, enforceable regulatory structure in place — one designed to make sure the skincare, makeup, and personal care items people use every day meet real safety standards.
What MoCRA Is Trying to Accomplish
At its core, MoCRA is meant to improve consumer safety and transparency, while bringing U.S. cosmetics regulation more in line with standards used elsewhere in the world. It does this by making compliance mandatory rather than optional and by giving the FDA new enforcement authority to back it up.
The Law's Core Requirements
MoCRA lays out a number of new obligations for cosmetic manufacturers, distributors, and brand owners:
Facility Registration — With some exemptions, any facility that manufactures or processes cosmetics for sale in the U.S. must register through the FDA's Cosmetics Direct portal.
Product Listing — A designated "responsible person" must submit a listing for each product to the FDA, covering details like ingredients and manufacturer information, subject to certain exemptions.
Safety Substantiation — Companies and individuals marketing cosmetics must keep documentation showing their products are safe for consumers to use.
Adverse Event Reporting — Serious adverse events linked to a cosmetic product must be reported to the FDA within a set window of time, giving the agency better visibility into problems after products hit the market.
Good Manufacturing Practices (GMP) — The FDA is directed to establish mandatory GMP standards to keep product quality and safety consistent.
Recall Authority and Records Access — For the first time, the FDA can order a recall of an unsafe cosmetic product and can request access to safety records during inspections.
Who Needs to Comply
MoCRA's reach extends across the entire cosmetics supply chain, touching:
Manufacturers and processors
The responsible person for each product
Importers bringing cosmetic products into the U.S.
Each of these parties needs to meet the law's requirements around registration, product listing, and safety documentation in order to legally sell their products.
What This Means for the Industry
MoCRA shifts cosmetics regulation from a system built on voluntary participation to one that's mandatory and enforceable. The result is more transparency, stronger consumer protections, and greater accountability industry-wide.
For companies, that means regulatory compliance now needs to be built into product development, manufacturing, and ongoing monitoring after products are on shelves. For consumers, it means more confidence that the products they're buying have actually been vetted for safety.
Final Thoughts
MoCRA fundamentally changes how cosmetics are regulated in the United States. By broadening the FDA's authority and introducing a full set of compliance obligations, the law raises the bar for product safety across the board. As the details of implementation continue to unfold, MoCRA is set to play a central role in building a cosmetics industry that's more transparent, accountable, and focused on protecting consumers.
Learn how Australia's PIC/S GMP framework impacts dietary supplement and food manufacturers. Ensure TGA compliance and streamline market access with Freyr.
Australia PIC/S GMP Framework for Dietary Supplements |Freyr
Navigating Australia's PIC/S GMP Requirements: What Dietary Supplement and Nutraceutical Manufacturers Need to Know
Regulatory scrutiny of health and wellness products is intensifying worldwide, and Australia stands out as one of the toughest markets to crack. Through its adoption of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) Good Manufacturing Practice (GMP) standards, the country has built a compliance framework that reaches well beyond conventional pharmaceuticals — touching dietary supplements, complementary medicines, and a range of products that may be classified as therapeutic goods.
For companies eyeing the Australian market, getting a handle on how PIC/S GMP shapes manufacturing, quality systems, and regulatory obligations isn't optional — it's foundational to a successful launch. Many businesses still think of GMP as a pharma-only concern, but Australia's framework increasingly pulls health supplements and wellness products into its orbit whenever those products meet the definition of therapeutic goods.
As global regulatory expectations keep shifting, manufacturers need to figure out early whether their products will be treated as food, supplement, or therapeutic goods in Australia — because the answer determines everything downstream.
Why PIC/S GMP Matters Beyond Pharmaceuticals
PIC/S is an international system that aligns manufacturing quality standards across regulated health products. In Australia, the Therapeutic Goods Administration (TGA) applies these PIC/S GMP standards to anything classified as a therapeutic good — a category that captures many complementary medicines and health supplements.
That matters because products sold elsewhere in the world as ordinary dietary supplements or nutraceuticals can land in an entirely different regulatory bucket once they reach Australia. The classification depends on factors like:
The ingredients used
Any therapeutic or health-related claims made
Dosage strength
How the product is presented and its intended use
The manufacturing process and formulation
So a product that sails through as a supplement in one country may suddenly face far stricter manufacturing and compliance demands in Australia.
Why This Should Be on Every Supplement and Food Manufacturer's Radar
Australia doesn't regulate supplements primarily as food products the way many markets do. Instead, products containing certain botanicals, vitamins, minerals, or probiotics — combined with how they're used, presented, dosed, and marketed — often get pulled into the complementary medicine category, which brings tighter GMP obligations with it.
That reclassification risk means exporters may need to revisit their manufacturing systems, product positioning, and regulatory strategy well before entering the market. Categories most likely to be affected include:
Dietary supplements
Nutraceuticals and food supplements
Foods carrying therapeutic-style claims
Botanical and herbal products
Probiotics
Sports nutrition
Immune health formulas
Functional beverages making health claims
Getting ahead of classification questions early can save companies from expensive delays down the line.
Rising Expectations Around Quality and Manufacturing
Australian regulators are steadily raising the bar on product quality, manufacturing consistency, and consumer safety. Companies should expect closer attention to:
Manufacturing facilities — Producers may need to show that their quality controls genuinely align with GMP expectations, not just claim they do.
Ingredient traceability — Stronger systems are expected for tracking raw materials, qualifying suppliers, and verifying ingredients.
Documentation and batch records — Regulators want thorough manufacturing records that demonstrate traceability and consistent production.
Product testing — Identity, purity, contaminant, and stability testing are all coming under greater scrutiny.
Supply chain oversight — With ingredients sourced globally, companies face growing pressure to tighten supplier compliance and verification processes.
Businesses that lean on contract manufacturers or international ingredient suppliers will feel these pressures most acutely.
What This Means for Companies Entering the Australian Market
For supplement companies expanding internationally, Australia's rules can reshape both market entry strategy and timelines. Common hurdles include:
Products being reclassified as complementary medicines
New manufacturing compliance requirements
GMP evidence expectations for manufacturing sites
Heavier documentation and quality-control burdens
Delays during registration or regulatory review
Reformulation needs driven by ingredient restrictions
Holding a cGMP certificate from the US, Europe, or Asia doesn't guarantee automatic acceptance in Australia — local expectations still have to be met on their own terms.
The Blurring Line Between Food and Therapeutic Products
Globally, the gap between "food" and "therapeutic product" keeps narrowing — and Australia is no exception. Functional foods, fortified drinks, botanical wellness items, immunity boosters, cognitive-health formulas, and metabolic-health supplements all draw more regulatory attention as their claims become bolder.
That leaves manufacturers needing to carefully weigh:
Formulation strategy
Marketing language and claims
Regulatory status of ingredients
Manufacturing quality requirements
How the product will be classified in this specific market
Australia decides classification case by case, based on composition, dosage form, presentation, intended purpose, and claims — so a product's status elsewhere offers no guarantee of how it'll be treated here. Getting the classification wrong can mean real compliance exposure and blocked market access.
What's at Stake for Non-Compliant Businesses
Underestimating Australia's regulatory framework can carry serious consequences, including:
Import restrictions
Enforcement action
Delayed launches
Product recalls
Manufacturing investigations
Costly reformulation
Supply chain disruption
Damage to brand trust
As regulators worldwide move toward harmonized standards, a compliance stumble in one market can ripple into expansion plans elsewhere.
How to Prepare
Companies planning to sell supplements, nutraceuticals, or functional health products in Australia should start their regulatory homework early. Practical steps include:
Running a product classification assessment
Reviewing the regulatory status of each ingredient
Auditing manufacturing quality systems
Reviewing claims and labeling language
Checking supplier compliance documentation
Strengthening traceability systems
Mapping the regulatory pathway before launch
Early groundwork here consistently pays off by avoiding costly surprises later.
How Freyr Can Help
Successfully entering the Australian market takes more than a working knowledge of food regulations — it requires understanding exactly where a product sits along the spectrum from food to dietary supplement to complementary medicine to therapeutic good.
Freyr helps manufacturers navigate this shifting landscape through:
Product classification and regulatory pathway assessments
Dietary supplement regulatory consulting
Labeling and claims compliance review
Ingredient compliance assessment
Market-specific regulatory intelligence
GMP gap assessments
Regulatory documentation review
Australia market-entry strategy
End-to-end compliance support across global food and supplement markets
By identifying regulatory risks early, Freyr helps companies prepare for market entry and manage compliance across the full product lifecycle.
Conclusion
Australia's continued alignment with PIC/S GMP standards reflects a broader global push toward tighter oversight of health-related consumer products. For companies in the dietary supplement, nutraceutical, functional food, and wellness spaces, compliance can no longer stop at formulation and labeling.
As the lines between food, supplements, and therapeutic goods keep shifting, manufacturers need to think carefully about classification, manufacturing standards, and country-specific rules before expanding into new territory. For businesses focused on sustainable global growth, early regulatory planning isn't just good practice — it's becoming essential. Partnering with experienced regulatory consultants like Freyr can help companies chart a clear path through complex requirements, reduce compliance risk, and move faster into new markets.